Patients with well-managed hypothyroidism on stable levothyroxine replacement can generally proceed with GLP-1 therapy if clinically indicated
As Healio previously reported, top-line data from the FLOW trial, published in The New England Journal of Medicine in May, showed adults with type 2 diabetes and chronic kidney disease treated with semaglutide had significantly reduced risks for major kidney disease events, CV outcomes and all-cause mortality vs
Conclusion We concluded that extracellular vimentin regulates expression of molecules in energy metabolism and promotes adipocyte hypertrophy
The ROS level was determined by measuring the fluorescence intensity of DCF using flow cytometer
Building on a 62-year legacy of community support, Weight Watchers deeply experienced Coaches along with a growing group of physicians who will also lead select groups help members navigate the real-life challenges of sustainable weight management
I share this story with patients not just because it is fascinating, but because it often shifts how they think about these medications